Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on June 11, 2015. The filing serves to announce financial results for the fiscal quarter and fiscal year ended March 31, 2015. The full details of these results are contained in a press release furnished as Exhibit 99.1, which is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), the text of which is not included in the input source.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. It only confirms that results for the quarter and year ended March 31, 2015, were announced.
Guidance, Outlook, and Risks
The report includes standard forward-looking statements regarding the company's intentions, beliefs, expectations, and strategies. Management notes that these statements are based on current assumptions and are not guarantees of future performance. Actual results may differ materially due to risks and uncertainties discussed in the company's Annual Report on Form 10-K. The company explicitly states it does not undertake an obligation to update these forward-looking statements except as required by law.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net income, cash position) by reviewing the attached Exhibit 99.1 Press Release, as they are absent from the 8-K body text.
- Confirm the registrant name is Oculus Innovative Sciences, Inc. and not Sonoma Pharmaceuticals, Inc.
- Review the company's most recent Form 10-K for the detailed risk factors referenced in the forward-looking statements disclaimer.
- Check the fiscal calendar to ensure the "year ended March 31, 2015" aligns with the company's fiscal year-end.